Astera Labs Shares Plunge After Massive Insider Sales
Prearranged executive stock disposals exposed the high‑valuation, low‑liquidity stock to selling pressure from geopolitical shocks and index flows.
Overview
- Astera Labs stock fell as much as 14% on Monday, dropping from about $413 to roughly $353 during a thin trading session.
- Reports show large insider sales executed under Rule 10b5‑1 plans drove part of the move, with aggregated insider disposals of roughly $507 million over the past quarter.
- Public filings conflict over the size of Board Chairman Manuel Alba’s trades, with one SEC Form 4 showing a July 1 sale of 8,491 shares while other regulatory summaries attribute 173,366 shares to him.
- Trading volume was unusually light at about 547,000 shares versus a typical daily average near 5.6 million, which amplified price swings as Nasdaq‑100 inclusion flows and recent U.S. strikes on Iran pushed investors toward safer assets.
- The company’s fundamentals remain strong, with the latest quarter showing $308 million in revenue, up 93.5% year over year and EPS of $0.61, but the episode highlights how visible insider liquidity and index mechanics can quickly pressure high‑multiple growth stocks.